Canfor Pulp Products Inc. (TSX:CFX)

Theseus Pharmaceuticals Statistics

Total Valuation

TSX:CFX has a market cap or net worth of CAD 41.75 million. The enterprise value is 117.05 million.

Market Cap	41.75M
Enterprise Value	117.05M

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CFX has 65.23 million shares outstanding.

Current Share Class	65.23M
Shares Outstanding	65.23M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	17.52%
Float	29.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.06
PB Ratio	0.24
P/TBV Ratio	0.24
P/FCF Ratio	2.82
P/OCF Ratio	0.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.33, with an EV/FCF ratio of 7.91.

EV / Earnings	-0.76
EV / Sales	0.16
EV / EBITDA	2.33
EV / EBIT	20.54
EV / FCF	7.91

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.43.

Current Ratio	0.98
Quick Ratio	0.19
Debt / Equity	0.43
Debt / EBITDA	1.52
Debt / FCF	5.18
Interest Coverage	0.54

Financial Efficiency

Return on equity (ROE) is -60.90% and return on invested capital (ROIC) is 1.04%.

Return on Equity (ROE)	-60.90%
Return on Assets (ROA)	0.66%
Return on Invested Capital (ROIC)	1.04%
Return on Capital Employed (ROCE)	2.56%
Revenue Per Employee	914,143
Profits Per Employee	-192,616
Employee Count	799
Asset Turnover	1.36
Inventory Turnover	3.87

Taxes

Income Tax	-56.60M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.67% in the last 52 weeks. The beta is 0.81, so TSX:CFX's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-29.67%
50-Day Moving Average	0.70
200-Day Moving Average	0.77
Relative Strength Index (RSI)	37.77
Average Volume (20 Days)	26,209

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CFX had revenue of CAD 730.40 million and -153.90 million in losses. Loss per share was -2.36.

Revenue	730.40M
Gross Profit	156.70M
Operating Income	5.70M
Pretax Income	-210.50M
Net Income	-153.90M
EBITDA	49.60M
EBIT	5.70M
Loss Per Share	-2.36

Balance Sheet

The company has 1.30 million in cash and 76.60 million in debt, giving a net cash position of -75.30 million or -1.15 per share.

Cash & Cash Equivalents	1.30M
Total Debt	76.60M
Net Cash	-75.30M
Net Cash Per Share	-1.15
Equity (Book Value)	176.80M
Book Value Per Share	2.71
Working Capital	-5.20M

Cash Flow

In the last 12 months, operating cash flow was 53.30 million and capital expenditures -38.50 million, giving a free cash flow of 14.80 million.

Operating Cash Flow	53.30M
Capital Expenditures	-38.50M
Free Cash Flow	14.80M
FCF Per Share	0.23

Margins

Gross margin is 21.45%, with operating and profit margins of 0.78% and -21.07%.

Gross Margin	21.45%
Operating Margin	0.78%
Pretax Margin	-28.82%
Profit Margin	-21.07%
EBITDA Margin	6.79%
EBIT Margin	0.78%
FCF Margin	2.03%

Dividends & Yields

TSX:CFX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-368.63%
FCF Yield	35.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CFX has an Altman Z-Score of 0.86 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.86
Piotroski F-Score	6